
Resolving the spatial heterogeneity of the tumor microenvironment is a key factor to understanding disease progression, therapeutic efficacy, and resistance.
Unbiased, whole transcriptome spatial profiling at single cell scale enabled by the Visium HD 3’ assay offers the discovery power to reveal global organization of cell types and states, cell–cell interactions, and molecular pathways that could guide our understanding of cancer and lead to new biomarkers or therapeutic strategies. Plus, 3’ poly(A) chemistry enables a hypothesis-free approach to explore tumor biology, including feasibility to detect isoforms, lncRNAs, and SNVs.
Download our AACR 2025 poster to see Visium HD 3’ data from human breast, pancreatic, and lung cancer. Find out how it revealed:
